PD-Rx Pharmaceuticals, Inc. is recalling 14,030 bottles of Doxycycline Hyclate tablets USP (100 mg), a prescription antibiotic used to treat various bacterial infections. The recall was initiated because the tablets failed dissolution specifications, meaning they may not dissolve properly in the body to release the active medication. This issue affects multiple bottle sizes ranging from 6-count to 400-count containers distributed nationwide across the United States. Consumers should contact their healthcare provider or pharmacist regarding the effectiveness of their medication.
If the medication does not dissolve according to specifications, the drug may not be fully absorbed by the body. This could lead to lower-than-intended blood levels of the antibiotic, potentially resulting in a failure to treat the underlying bacterial infection effectively.
Full refund and healthcare consultation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.